Gainers
$Verso(VRS.US)$ rose 32% to $26.45 in pre-market trading after the company agreed to be acquired by BillerudKorsnäs AB for $27 per share in cash.
$Society Pass(SOPA.US)$ rose 23% to $4.07 in pre-market trading after the company reported addition to the Russell 2000 Index.
$Ocugen(OCGN.US)$ rose 10.3% to $5.78 in pre-market trading. Ocugen recently announced that immune response data following two doses of Covaxin from a third-party study were published on the preprint server, medRxiv.
$Alpha Pro Tech(APT.US)$ rose 9.8% to $6.60 in pre-market trading. Alpha Pro Tech recently added $2 million to its buyback program.$GBS Inc(GBS.US)$ rose 9.5% to $1.38 in pre-market trading after dipping 23% on Friday. GBS recently announced application for FDA breakthrough device designation to fast track rapid saliva glucose test.
$Calliditas Therapeutics(CALT.US)$ rose 9.4% to $25.67 in pre-market trading. Calliditas Therapeutics recently announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.
$SeaChange International(SEAC.US)$ rose 7.8% to $1.66 in pre-market trading after declining around 8% on Friday. SeaChange recently reported better-than-expected Q3 results.
$Novavax(NVAX.US)$ rose 7.7% to $233.97 in pre-market trading. Novavax and Serum Institute of India said the World Health Organization has granted Emergency Use Listing for NVX-CoV2373 COVID-19 vaccine.
$Allied Healthcare Products(AHPI.US)$ rose 6.4% to $6.17 in pre-market trading after gaining around 4% on Friday.
Losers
$Spruce Biosciences(SPRB.US)$ fell 16.5% to $4.20 in pre-market trading. Spruce Biosciences shares jumped more than 102% on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15 price target.
$Bellerophon Therapeutics(BLPH.US)$ fell 16.3% to $2.67 in pre-market trading. Bellerophon Therapeutics jumped around 35% on Friday after topline data from Phase 2 study (PULSE-PHPF-002) evaluating the acute hemodynamic benefit of INOpulse via right heart catheterization for pulmonary hypertension associated with sarcoidosis (PH-Sarc)..
$Immix Biopharma(IMMX.US)$ fell 12% to $3.52 in pre-market trading amid post-IPO volatility.
$Iris Energy(IREN.US)$ fell 11.9% to $15.6 in pre-market trading after climbing 26% on Friday.
$Turkcell Iletisim Hizmetleri(TKC.US)$ fell 11.9% to $2.97 in pre-market trading after declining around 6% on Friday.
$cbdMD(YCBD.US)$ shares fell 10.5% to $1.19 in pre-market trading. cbdMD reported FY21 net sales of $44.5 million, versus $41.8 million in FY20.
$Argo Blockchain(ARBK.US)$ fell 9.4% to $11.75 in pre-market trading after rising around 5% on Friday.
$Zhihu(ZH.US)$ shares fell 8.9% to $5.21 in pre-market trading.
$Eloxx Pharmaceuticals(ELOX.US)$ shares fell 6.7% to $0.689 in pre-market trading. Eloxx Pharmaceuticals shares climbed 12% on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $4 price target.
$Arqit Quantum(ARQQ.US)$ shares fell 6% to $18.7 in pre-market trading after jumping 22% on Friday.
$Catalyst Biosciences(CBIO.US)$ fell 6% to $0.9494 in pre-market trading.
$Laredo Petroleum(LPI.US)$ fell 4.4% to $56.4 in pre-market trading.
Comment(0)
Reason For Report